Research Progress and Challenges of Anti-monkeypox Virus Drugs Targeting F13 Protein.
Future paradigms must break away from standalone F13 monotherapy and transition toward combination regimens, such as pairing F13 blockers with host-targeting entry/uncoating inhibitors─or developing multitarget inhibitors that interrupt the viral life cycle prior to IMV maturation by targeting DNA polymerase or transcr...